Your search returned 21 results.

Results
	1.	The management of neuroendocrine tumours: current and future medical therapy options. [electronic resource] by Oberg, K E Producer: 20120815 In: Clinical oncology (Royal College of Radiologists (Great Britain)) vol. 24 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	2.	The reversibility of the respiratory inhibition in gills and the ultrastructural changes in chloride cells from the rotenone-poisoned marine teleost, Gadus callarias L. [electronic resource] by Oberg, K E Producer: 19670619 In: Experimental cell research vol. 45 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	3.	THE INHIBITION OF THE RESPIRATION OF BRAIN MITOCHONDRIA OF ROTENONE-POISONED FISH. [electronic resource] by OBERG, K E Producer: 19961201 In: Experimental cell research vol. 36 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	4.	The site of the action of rotenone in the respiratory chain. [electronic resource] by OBERG, K E Producer: 19981101 In: Experimental cell research vol. 24 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	5.	Gastrointestinal neuroendocrine tumors. [electronic resource] by Öberg, K E Producer: 20111017 In: Annals of oncology : official journal of the European Society for Medical Oncology vol. 21 Suppl 7 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	6.	Autoimmunity and antibodies to interferons in patients with carcinoid tumors--clinical consequences. [electronic resource] by Oberg, K E Producer: 19950214 In: Journal of interferon research vol. 14 Availability: No items available. Save to lists Add to cart (remove)
	7.	The effect of rotenone on respiration and its point of attack. [electronic resource] by LINDAHL, P E OBERG, K E Producer: 19981101 In: Experimental cell research vol. 23 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	8.	Mechanism of the physiological action of rotenone. [electronic resource] by LINDAHL, P E OBERG, K E Producer: 19981101 In: Nature vol. 187 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	9.	Antibodies to interferon-alpha in treated cancer patients: incidence and significance. [electronic resource] by McKenna, R M Oberg, K E Producer: 19970610 In: Journal of interferon & cytokine research : the official journal of the International Society for Interferon and Cytokine Research vol. 17 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	10.	Carcinoid tumours. [electronic resource] by Tiensuu Janson, E M Oberg, K E Producer: 19970728 In: Bailliere's clinical gastroenterology vol. 10 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	11.	Possible induction of systemic lupus erythematosus by interferon-alpha treatment in a patient with a malignant carcinoid tumour. [electronic resource] by Rönnblom, L E Alm, G V Oberg, K E Producer: 19900420 In: Journal of internal medicine vol. 227 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	12.	Autoimmunity after alpha-interferon therapy for malignant carcinoid tumors. [electronic resource] by Rönnblom, L E Alm, G V Oberg, K E Producer: 19910730 In: Annals of internal medicine vol. 115 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	13.	Oncolytic viruses for the treatment of neuroendocrine tumors. [electronic resource] by Essand, M Leja, J Giandomenico, V Oberg, K E Producer: 20120315 In: Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme vol. 43 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	14.	Octreotide and interferon alfa: a new combination for the treatment of malignant carcinoid tumours. [electronic resource] by Tiensuu Janson, E M Ahlström, H Andersson, T Oberg, K E Producer: 19921103 In: European journal of cancer (Oxford, England : 1990) vol. 28A Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	15.	Characterization of anti-interferon-alpha antibodies appearing during recombinant interferon-alpha 2a treatment. [electronic resource] by Rönnblom, L E Janson, E T Perers, A Oberg, K E Alm, G V Producer: 19921007 In: Clinical and experimental immunology vol. 89 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	16.	Liver embolizations of patients with malignant neuroendocrine gastrointestinal tumors. [electronic resource] by Eriksson, B K Larsson, E G Skogseid, B M Löfberg, A M Lörelius, L E Oberg, K E Producer: 19981216 In: Cancer vol. 83 Availability: No items available. Save to lists Add to cart (remove)
	17.	The use of new somatostatin analogues, lanreotide and octastatin, in neuroendocrine gastro-intestinal tumours. [electronic resource] by Eriksson, B Janson, E T Bax, N D Mignon, M Morant, R Opolon, P Rougier, P Oberg, K E Producer: 19970114 In: Digestion vol. 57 Suppl 1 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	18.	Treatment with cisplatin and etoposide in patients with neuroendocrine tumors. [electronic resource] by Fjällskog, M L Granberg, D P Welin, S L Eriksson, C Oberg, K E Janson, E T Eriksson, B K Producer: 20011004 In: Cancer vol. 92 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	19.	Efficacy of everolimus plus octreotide LAR in patients with advanced neuroendocrine tumor and carcinoid syndrome: final overall survival from the randomized, placebo-controlled phase 3 RADIANT-2 study. [electronic resource] by Pavel, M E Baudin, E Öberg, K E Hainsworth, J D Voi, M Rouyrre, N Peeters, M Gross, D J Yao, J C Publication details: Annals of oncology : official journal of the European Society for Medical Oncology 12 2019 In: Annals of oncology : official journal of the European Society for Medical Oncology vol. 30 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	20.	Efficacy of everolimus plus octreotide LAR in patients with advanced neuroendocrine tumor and carcinoid syndrome: final overall survival from the randomized, placebo-controlled phase 3 RADIANT-2 study. [electronic resource] by Pavel, M E Baudin, E Öberg, K E Hainsworth, J D Voi, M Rouyrre, N Peeters, M Gross, D J Yao, J C Producer: 20180129 In: Annals of oncology : official journal of the European Society for Medical Oncology vol. 28 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)

Refine your search

Availability

Authors

Topics

Languages

Your search returned 21 results.